• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Depression Treatment Advancements

While effective treatments for depression are available, researchers are working on new and more effective ways to treat the disorder. This special Research in Context feature will explore some of these advancements in depression treatment.

Psychotherapy can help ease depression symptoms by educating the person how to handle negative thoughts and feelings. Talk therapy can be performed one-on-one with a health professional or in a group setting.

Precision mental healthcare

The term "precision" refers to the ability to bring greater precision or accuracy to prevention, diagnosis and treatment methods. In the case of mental health, this includes various approaches ranging from medications to psychotherapy. Many of these strategies concentrate on the symptoms of the disorder, instead of the root cause. This can result in treatments that do nothing more than ease symptoms but do not address the underlying factors that lead to mental illness in the initial place.

Precision mental healthcare is rapidly advancing. It's similar to the method that is used in other areas, such as incorporating constant monitoring of key indicators (e.g. fever or blood pressure) into clinical practice. It also includes combining multiple sources of data and utilizing machine learning to help physicians better understand a patient's individual needs and formulate more effective treatment strategies.

One example of precision psychiatry involves using EEG to determine brain activity and assist doctors assess the ability of a person to engage in cognitive behavior therapy. A new class of medications known as NMDA receptor inhibitors could reduce symptoms of depression treatment options by preventing the neurotransmitter, glutamate, from reaching certain brain cells. Another possible breakthrough is the use of pharmacogenetic testing to detect drug-gene interactions and avoid unfavorable side effects.

Many companies are also exploring digital precision medicine, which makes use of objective digital technology to monitor patients remotely and collect real-time data that aids in their treatment. One example is that a company is leveraging artificial intelligence to monitor compliance and optimize dosages for their patients suffering from depression. These solutions have the potential of enhancing accessibility and efficiency in mental health care as well as improving the patient's adherence to treatment.

Digital precision psychiatry in particular, can help people with mental illness overcome barriers to treatment, especially those who are working. Johnson & Johnson, for example, has partnered with organizations in Singapore to help facilitate the reintegration of people recovering from depression back into their workplaces. This can help them maintain their jobs, which is essential for the recovery of mental health.

Medication

Many people suffering from depression find that medication eases their symptoms. This is particularly relevant if the symptoms are severe or incapacitating. Antidepressants help restore the balance of neurotransmitters in the brain which are chemical messengers that regulate mood and emotional state. Most current antidepressants target one of these neurotransmitters, boosting levels of serotonin, norepinephrine, and dopamine. Selective serotonin-reuptake inhibition (SSRIs), like Prozac and Zoloft increase the levels of serotonin, a chemical in the brain. SNRIs such as Cymbalta, Effexor and Cymbalta are able to target both norepinephrine and dopamine. Monoamine Oxase inhibitors like Wellbutrin focus on only dopamine and norepinephrine.

Most doctors recommend antidepressants for an initial treatment for depression, along with some form of therapy for talk. Some of these therapies are cognitive behavioural therapy (CBT), which helps improve feelings and thoughts by teaching specific skills or psychotherapy for interpersonal relationships (which concentrates on improving relationships). Other therapies, such as electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) are also known to have been proven to be effective in treating depression.

Some people, however, don't respond to the initial medication that doctors prescribe. A third of people suffering from depression do not get any relief from their first medication and about 40 percent who begin taking antidepressants cease within three months. Recent research has allowed doctors to predict which medications is most effective for a person by using blood or MRI tests to determine which receptors have been most affected by depression.

The quality of medication has improved in recent years, with a wider range of options and higher doses to help minimize adverse effects. For instance, antidepressants that are more recent such as esketamine (Spravato), the brexanolone (Auvelity) and nefazodone (Sertraline) work to rapidly alleviate depression during pregnancy treatment symptoms by stimulating glutamate activity in the brain.

Clinical trials are underway on different medications that could change the way they are used. A drug known as Vorapaxar is being tested on humans. It targets a distinct part of the brain that is that is associated with depression by blocking NMDA receptors. It's expected to become available in 2024. Another medication that has demonstrated potential is a combination of bupropion and ketamine, which may be more effective in treating treatment-resistant depression.

Psychotherapy

Psychiatric researchers have been able to pinpoint certain factors that cause depression, for instance, problems with the neurotransmitters serotonin as well as norepinephrine. These chemicals are vital in controlling mood and emotions, as well as the overall function of the brain. Medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors are the main treatment options. They can ease many of depression-related symptoms, including depressed feelings and fatigue, and increase appetite, sleep and energy levels. They are not without side effects, which can make them unsuitable to some people.

Psychotherapy can address root causes of depression treatment London and help people cope with psychotic depression treatment. Cognitive therapy for behavior and ketamine therapy are two types of therapy that have been found to decrease depression symptoms. In addition, psychotherapy can help people develop a more healthy way of coping and to manage stressors. However, access to psychotherapy can be restricted by costs and scheduling limitations as well as a shortage of mental health providers. The recent growth of the telehealth industry has increased access for some individuals.

Finding the right treatment combination is key to overcoming depression treatment without drugs. The use of medication alone isn't enough to alleviate all your symptoms, and it may take between 6 and 12 weeks before you can tell whether a medication is working. There are several nonpharmacologic treatment options, including transcranial magnetic stimulation that is repeated and vagus nervous stimulation. These therapies employ electromagnetic fields to improve mood and increase the brain's chemical.

Whether you're interested in trying medication or psychotherapy it is essential to be in close contact with your provider. Talk openly about your thoughts and feelings and discuss the benefits, risks, and side effects of each method. If you have a hard getting a good rapport with your doctor or therapist Try to find a provider who can meet your requirements. A service that provides a trial period free of charge can also be a good choice, as it gives you the chance to test different options before committing. Eventually, you'll find a treatment that works best for you and allows you to feel your best.

Brain stimulation

In a few short years, scientists have come up with new methods to target specific areas of the brain and swiftly alter their functioning. These techniques can be utilized to treat physical ailments and some mental disorders.

rTMS is a technique which employs electromagnetic pulses to stimulate brain activity. It's similar to magnetic pulses that are used in MRIs but not sufficient to trigger seizures. The technique works by stimulating a specific area of the head with an unpainful magnet. The pulsations alter the way that brain signals are processed which allows you to feel better. The treatment takes just 3.5 minutes and does not interfere with your normal routine. You may experience a slight headache afterward.

Another treatment involves putting electrodes in the brain to send painless electrical zaps. This procedure is also referred to as deep transcranial magnetic stimulation (deep TMS), and it's been used for OCD and to stop smoking cigarettes. It's still being studied for depression, but preliminary studies suggest that it could reduce depressive symptoms in some people. It's unclear how this treatment works however, it seems to alter the balance of certain Neurotransmitters.

Other forms of noninvasive brain stimulation are also advancing also. In a recent study patients suffering from severe depression and intolerance to antidepressants reacted well to a treatment using magnetics known as SAINT. It's personalized to each patient's brain anatomy and utilizes high-dose patterns of magnetic pulses. The treatment can be delivered in a few hours, unlike previous treatments that required daily sessions spread over weeks or months.

The researchers utilized fMRI to locate the precise region of the brain that was being stimulated in each patient. They also looked at the small differences in the activation of different brain regions, which helped determine the direction of the signals. They discovered that in patients suffering from depression the brain's anterior cingulate cortex sent signals to an area called the subgenual cingulate cortex. However, these signals were frequently misdirected, and the more severe depression was, the more of these wrong-way signals there were.